AQVESME is the only FDA-approved medicine for anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemiaMarketed under AQVESME brand name…
BENGALURU, India, Dec. 17, 2025 /PRNewswire/ -- Healthtech company Clinikk, building India's first integrated health system, has received approval from…
NEW YORK, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical…
First FDA approved treatment in 30+ years for more than 2 million Americans with PSVT Novel nasal spray designed to rapidly…
Sri Adhikari Brothers Television Network Limited (SABTNL) (BSE 530943) (NSE: SABTNL) (ISIN: INE416A01044), which is in the process of being renamed…
December 01, 2025 12:10 ET | Source: Airway Management, Inc. DALLAS, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Airway Management, the…
November 28, 2025 20:13 ET | Source: Rakovina Therapeutics Inc VANCOUVER, British Columbia, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Rakovina…
Dedicated to Nurturing a New Generation of DoctorsSupporting Hong Kong Become a Hub for Medical Innovation HONG KONG, Nov. 18,…
LONDON, Nov. 13, 2025 /PRNewswire/ -- Markel Insurance, the insurance operation within Markel Group Inc. (NYSE: MKL), today announced the…
November 05, 2025 08:00 ET | Source: LENZ Therapeutics, Inc. VIZZTM (aceclidine ophthalmic solution) 1.44% received FDA approval for the…